GlassScriptPhysician profile
Ramakrishna Tatineni
NPI 1457353252
$7,295.62
in general payments reported to CMS, 2019-2025
22 companies · $1,777 in 2025
The $1,777 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2021: $1,347 · 2022: $1,377 · 2023: $794 · 2024: $554 · 2025: $1,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,504 · Travel and Lodging: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,503.51 |
| Travel and Lodging | $621.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,961.19 | 2019-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $387.75 | 2023-2025 | Wallflex Duodenal, Spyscope Ds, Spyglass Discover |
| Ethicon US, LLC | $330.75 | 2021-2025 | Stratafix, Vistaseal, Echelon; Endopath |
| W. L. Gore & Associates, INC. | $313.31 | 2023-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Becton, Dickinson and Company | $245.23 | 2024 | Phasix Mesh |
| Davol INC. | $207.52 | 2023-2025 | Phasix Mesh |
| Stryker Corporation | $173.76 | 2023 | Spy-Phi System |
| Solventum Corporation | $110.52 | 2024 | Prevena |
| Medtronic, INC. | $109.93 | 2023-2025 | Sonicision, Progrip |
| Tela Bio, INC. | $108.88 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $77.09 | 2021-2022 | |
| Angiodynamics, INC. | $42.01 | 2023 | Smart Port Ct |
| Covidien LP | $39.73 | 2019 | |
| Heron Therapeutics, INC. | $26.61 | 2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $24.31 | 2025 | Exparel, Iovera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $24.21 | 2024 | Andexxa |
| E.R. Squibb & Sons, L.L.C. | $21.69 | 2021 | |
| Smith+Nephew, INC. | $20.63 | 2024 | Renasys Touch |
| Allergan, INC. | $20.42 | 2022 | |
| Lemaitre Vascular, INC. | $19.73 | 2023 | Artegraft Vascular Graft |
| Vioptix INC | $16.32 | 2024 | T. Ox Tissue Oximeter |
| Conmed Corporation | $14.03 | 2023 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramakrishna Tatineni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.